Case report reveals the diagnosis of heterotopic pregnancy after ectopic treatment, suggesting thorough follow-up is crucial.
Ectopic pregnancy (EP) refers to the implantation of a fertilized ovum outside the uterine cavity, most commonly in the fallopian tube. One key clinical marker is beta human chorionic gonadotropin (β-hCG), which typically declines following surgical removal of the ectopic tissue. Persistent or rising β-hCG post-removal often suggests incomplete removal, persistent ectopic tissue, or rarely gestational trophoblastic disease. However, a more elusive diagnosis is heterotopic pregnancy (HP), defined as the simultaneous occurrence of both intrauterine and extrauterine pregnancies. We present the case of a woman who underwent a salpingectomy for a ruptured EP diagnosed at 6 weeks gestation. Four weeks later, her β-hCG levels remained elevated. A transvaginal ultrasound revealed a viable intrauterine pregnancy (IUP) at 10 weeks’ gestation, confirming the diagnosis of HP. This case underscores the critical importance of comprehensive follow-up evaluation when β-hCG levels remain elevated after EP management. A combination of clinical assessment, serial β-hCG monitoring, point-of-care ultrasound, and formal transvaginal imaging must be employed to exclude the presence of HP and optimize patient outcomes.
No takes yet. Share an insight, caveat, or question.
Habboub et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: